VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 29, 2026. The…
Viridian Eye Disease Drug Disappoints on Efficacy Despite Trial Success
Viridian Therapeutics’ experimental treatment for thyroid eye disease lagged rivals in efficacy in a late-stage… Reuters Health Information
Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced positive top…
Five commonly missed retinal conditions and how to address them
MIAMI — At Sunshine Eye and Retina, Rishi P. Singh, MD, shared advice with comprehensive ophthalmologists for addressing five commonly missed retinal diagnoses.“You guys see these patients all the time. You diagnose them first, and you then have to dec…
Innovation, technology evolving in ophthalmology
MIAMI — Innovation and technology are evolving to meet the need of “an aging population that needs our care now more than ever,” according to Matt Jensen, MBA.“We just don’t have enough doctors to get to them,” he said during a presentation at Sunshine…
Uveitis findings determine referral urgency
MIAMI — Exam findings will show a comprehensive ophthalmologist when to refer a patient for uveitis, according to a speaker at Sunshine Eye & Retina.Sumit Sharma, MD, said clinicians should be able to recognize red flags that call for immediate referra…